Drug Resistance Among Drug-naive and First-line Antiretroviral Treatment-failing Children in Cameroon-Reference-Cited by-同舟云学术

Drug Resistance Among Drug-naive and First-line Antiretroviral Treatment-failing Children in Cameroon

Published:2011-12 Issue:12 Volume:30 Page:1062-1068
ISSN:0891-3668
Container-title:Pediatric Infectious Disease Journal
language:en
Short-container-title:

Author:

Fokam Joseph,Salpini Romina,Santoro Maria Mercedes,Cento Valeria,Perno Carlo-Federico,Colizzi Vittorio,Ndumbe Peter Martins,Fokunang Ntungen Charles,Ndiang Tetang Suzie Moyo,Nanfack Aubin Joseph,Takou Komego Désiré Augustin,Cappelli Giulia

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Infectious Diseases,Microbiology (medical),Pediatrics, Perinatology and Child Health

Reference43 articles.

1. . Scaling up access to antiretroviral treatment for HIV infection: the impact of decentralization of healthcare delivery in Cameroon.;Boyer;AIDS,2010

2. . Effectiveness and safety of a generic fixed dose combination of stavudine, lamivudine and nevirapine in HIV-1 infected adults in Cameroon: open label multicentric trial.;Vergne;Lancet,2004

3. . HIV-1 drug resistance mutations among newly diagnosed patients before scaling up in Burkina Faso and Cameroon.;Vergne;Antivir Ther,2006

4. . Long-term safety, effectiveness and quality of a generic fixed-dose combination of nevirapine, stavudine and lamivudine.;Laurent;AIDS,2007

5. . Evaluation of transmitted HIV drug resistance among recently-infected antenatal clinic attendees in four Central African countries.;Aghokeng;Antivir Ther,2009

Cited by 33 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. High performance of integrase genotyping on diverse HIV-1 clades circulating in Cameroon: toward a successful transition to dolutegravir-based regimens in low and middle-income countries;Diagnostic Microbiology and Infectious Disease;2022-02

2. Archiving of mutations in HIV‐1 cellular reservoirs among vertically infected adolescents is contingent with clinical stages and plasma viral load: Evidence from the EDCTP‐READY study;HIV Medicine;2021-12-23

3. Determinants of switch to paediatric second‐line antiretroviral therapy after first‐line failure in Cameroon;Tropical Medicine & International Health;2021-05-13

4. Baseline integrase drug resistance mutations and conserved regions across HIV-1 clades in Cameroon: implications for transition to dolutegravir in resource-limited settings;Journal of Antimicrobial Chemotherapy;2021-01-27

5. Evaluation of treatment response, drug resistance and HIV-1 variability among adolescents on first- and second-line antiretroviral therapy: a study protocol for a prospective observational study in the centre region of Cameroon (EDCTP READY-study);BMC Pediatrics;2019-07-05